Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 5, 2008
Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial
William Kemp, John Colman, Kenneth Thompson, et al.
Plos One
|
December 20, 2014
Dexpramipexole is ineffective in two models of ALS related neurodegeneration
Fernando G Vieira, Eva LaDow, Andy Moreno, et al.
Journal of Agricultural and Food Chemistry
|
November 28, 2002
Flunixin residues in milk after intravenous treatment of dairy cattle with (14)C-flunixin
William F Feely, Cheryl Chester-Yansen, Kenneth Thompson, et al.
IBRO Reports
|
August 24, 2018
CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits
Fernando G Vieira, Theo Hatzipetros, Kenneth Thompson, et al.
Transactions of the American Ophthalmological Society
|
May 2, 2007
Reduction of preoperative conjunctival bacterial flora with the use of mupirocin nasal ointment
Terry J Alexandrou, Seenu M Hariprasad, Joseph Benevento, et al.
Neurobiology of Disease
|
June 5, 2025
Comprehensive characterization and validation of the Prp-hPFN1<sup>G118V</sup> mouse model: Guidelines for preclinical therapeutic testing for ALS
Kaly A Mueller, Emma G Suneby, Matthew H Ferola, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
February 15, 2008
Design, power, and interpretation of studies in the standard murine model of ALS
Sean Scott, Janice E Kranz, Jeff Cole, et al.
Scientific Reports
|
May 2, 2019
SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS
Cindy Gill, James P Phelan, Theo Hatzipetros, et al.
Plos One
|
August 20, 2015
Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS
Fernando G Vieira, Qinggong Ping, Andy J Moreno, et al.
Nature Genetics
|
March 30, 2010
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
John M Lincecum, Fernando G Vieira, Monica Z Wang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 5, 2008
Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial
William Kemp, John Colman, Kenneth Thompson, et al.
Plos One
|
December 20, 2014
Dexpramipexole is ineffective in two models of ALS related neurodegeneration
Fernando G Vieira, Eva LaDow, Andy Moreno, et al.
Journal of Agricultural and Food Chemistry
|
November 28, 2002
Flunixin residues in milk after intravenous treatment of dairy cattle with (14)C-flunixin
William F Feely, Cheryl Chester-Yansen, Kenneth Thompson, et al.
IBRO Reports
|
August 24, 2018
CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits
Fernando G Vieira, Theo Hatzipetros, Kenneth Thompson, et al.
Transactions of the American Ophthalmological Society
|
May 2, 2007
Reduction of preoperative conjunctival bacterial flora with the use of mupirocin nasal ointment
Terry J Alexandrou, Seenu M Hariprasad, Joseph Benevento, et al.
Neurobiology of Disease
|
June 5, 2025
Comprehensive characterization and validation of the Prp-hPFN1<sup>G118V</sup> mouse model: Guidelines for preclinical therapeutic testing for ALS
Kaly A Mueller, Emma G Suneby, Matthew H Ferola, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
February 15, 2008
Design, power, and interpretation of studies in the standard murine model of ALS
Sean Scott, Janice E Kranz, Jeff Cole, et al.
Scientific Reports
|
May 2, 2019
SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS
Cindy Gill, James P Phelan, Theo Hatzipetros, et al.
Plos One
|
August 20, 2015
Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS
Fernando G Vieira, Qinggong Ping, Andy J Moreno, et al.
Nature Genetics
|
March 30, 2010
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
John M Lincecum, Fernando G Vieira, Monica Z Wang, et al.
Page
of 4